BioSpace News Archive

Business

Quanterix to Release Third Quarter 2019 Financial Results and Host Conference Call on November 6, 2019

Quanterix Corporation announced that it will release its financial results for third quarter 2019 after the close of trading on Wednesday, November 6, 2019.

October 22, 2019
·
2 min read
Business

BioAegis Therapeutics Named New Jersey’s Most Valuable Venture-Backed Company Led by a Woman

BioAegis Therapeutics was recently recognized by PitchBook as the most valuable venture-backed company in New Jersey led by a female entrepreneur.

October 22, 2019
·
2 min read
Biotech Bay

Innovation in Neurosurgery: Mizuho America Announces New Dissection Set Designed by A Renowned Neurosurgeon, Dr. Youssef

When a 48 year old active young lady realized her hearing and balance were slowly deteriorating in performing her day to day activities, she consulted with her doctor and was referred to a neuro-otologist.

October 22, 2019
·
3 min read
BioMidwest

Aptar’s Activ-Blister™ Packaging Solution Approved by U.S. FDA for Oral Solid Dose HIV Prevention Medicine

AptarGroup, Inc. announced that its Activ-Blister™ packaging solution for oral solid dose drug delivery was recently approved by the U.S. Food and Drug Administration for a HIV prevention medicine..

October 22, 2019
·
2 min read
Business

Robert Dempsey Joins iVeena Board of Directors

iVeena Delivery Systems announces the appointment of Robert Dempsey, former Group Vice President and Head of the Global Ophthalmology Franchise at Shire/Takeda, to the iVeena Board of Directors.

October 22, 2019
·
3 min read
Business

Psychemedics Announces Third Quarter Results and Declares 93rd Consecutive Quarterly Dividend

Psychemedics Corporation announced third quarter financial results for the period ended September 30, 2019.

October 22, 2019
·
8 min read
Business

Harvard Bioscience Schedules Third Quarter 2019 Earnings Conference Call for November 5 at 4:30 PM ET

Harvard Bioscience, Inc. will announce its quarterly results for third quarter ended September 30, 2019 after market close on November 5, 2019 and hold a conference call to discuss the results for the third quarter on November 5, 2019 at 4:30 p.m.

October 22, 2019
·
1 min read
BioCapital

Gore and SCHOTT to Showcase Commercial Option for Packaging and Delivery of Silicone-Sensitive Biologics

W. L. Gore & Associates, Inc., a global materials science company has collaborated with SCHOTT, a pharma packaging specialist to develop a tested and validated option for packaging and delivery of silicone-sensitive biologics.

October 22, 2019
·
3 min read
Business

David Meline, Amgen’s Chief Financial Officer, To Retire

Amgen announced the planned retirement of David W. Meline, who has served as the company’s executive vice president and chief financial officer since 2014.

October 22, 2019
·
3 min read
Drug Development

APEIRON to present preclinical data at the 2019 AACR-NCI-EORTC Conference

APEIRON Biologics AG announced that it will present preclinical data for its clinical stage project APN401 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, 26-30 October 2019 in Boston, MA, USA.

October 22, 2019
·
2 min read